This study is looking at a new, non-invasive (no needles or surgery) device called the Rhaeos Shunt Monitoring System (RSMS). It's designed to check if your cerebrospinal fluid (CSF) shunt, which drains fluid from your brain if you have hydrocephalus, is working properly. Shunts can sometimes stop working, and it can be hard to tell if there's a problem without complex tests. The RSMS uses thermal sensing to detect fluid flow. We're comparing the RSMS to an existing FDA-cleared device called ShuntCheck III to see how well the new system identifies shunt flow. You may be able to join if you have an existing CSF shunt with a clear, palpable (can be felt) section of the shunt under your skin.

Study design

This is an interventional study with a planned enrollment of 85 participants. It compares the Rhaeos Shunt Monitoring System (RSMS) with ShuntCheck III.

What's involved

The primary endpoints are measured at Day 1 (study visit), suggesting a short participation period.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoints are measured at Day 1 (study visit).

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.